Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1976 1
1979 1
1980 1
1981 1
1982 6
1983 1
1985 3
1986 6
1987 5
1988 10
1989 9
1990 3
1991 5
1992 2
1993 5
1994 3
1999 1
2002 1
2003 1
2004 2
2005 1
2009 1
2010 3
2011 2
2012 3
2013 2
2014 1
2015 3
2016 1
2017 2
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

87 results
Results by year
Filters applied: . Clear all
Page 1
Safety pharmacology and risk assessment.
Kinter LB, Valentin JP. Kinter LB, et al. Fundam Clin Pharmacol. 2002 Jun;16(3):175-82. doi: 10.1046/j.1472-8206.2002.00104.x. Fundam Clin Pharmacol. 2002. PMID: 12165065 Review.
A defense of 'risk-benefit' terminology.
Kinter LB, Johnson DK. Kinter LB, et al. Lab Anim (NY). 2015 Oct;44(10):403-7. doi: 10.1038/laban.875. Lab Anim (NY). 2015. PMID: 26398615
Safety pharmacology in 2010 and beyond: survey of significant events of the past 10 years and a roadmap to the immediate-, intermediate- and long-term future in recognition of the tenth anniversary of the Safety Pharmacology Society.
Bass AS, Vargas HM, Valentin JP, Kinter LB, Hammond T, Wallis R, Siegl PK, Yamamoto K. Bass AS, et al. Among authors: kinter lb. J Pharmacol Toxicol Methods. 2011 Jul-Aug;64(1):7-15. doi: 10.1016/j.vascn.2011.05.006. Epub 2011 Jun 12. J Pharmacol Toxicol Methods. 2011. PMID: 21689769 Review.
Fit for Purpose Assessment: A New Direction for IACUCs.
Kinter LB, Johnson DK, Weichbrod RH, Prentice ED, Simmonds RC, Houghton PW, Whitney RA Jr, DeGeorge J, DeHaven WR, Kramer K, DeTolla L. Kinter LB, et al. ILAR J. 2022 May 4:ilac006. doi: 10.1093/ilar/ilac006. Online ahead of print. ILAR J. 2022. PMID: 35512294
87 results